BLCO
Bausch + Lomb Corporation
Price Chart
Latest Quote
$14.96
+0.10 (+0.67%)
Current Price
| Previous Close | $14.86 |
| Open | $14.88 |
| Day High | $15.00 |
| Day Low | $14.82 |
| Volume | 63,415 |
Stock Information
| Shares Outstanding | 356.54M |
| Total Debt | $5.07B |
| Cash Equivalents | $268.00M |
| Revenue | $5.21B |
| Net Income | $-219.00M |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Market Cap | $5.33B |
| EPS (TTM) | $-0.62 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $10.22B |
| Sales | $5.21B |
| Income | $-219.00M |
| Book/sh | $17.90 |
| Cash/sh | $0.75 |
| Employees | 13K |
Financial Ratios
| Quick Ratio | 0.76 |
| Current Ratio | 1.52 |
| Debt/Eq | 78.58 |
Returns & Margins
| ROA | 1.41% |
| ROE | -3.28% |
| Gross Margin | 60.62% |
| Operating Margin | 4.74% |
| Profit Margin | -4.21% |
Ownership
| Insider Ownership | 87.36% |
| Institutional Ownership | 11.01% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 13.91 |
| PEG | 0.89 |
| P/S | 1.02 |
| P/B | 0.84 |
Analyst Data
| Recommendation | buy |
| Target Price | $17.88 |
Technical Indicators
| SMA20 | $15.36 |
| SMA50 | $15.86 |
| SMA200 | $16.14 |
| RSI | 38.76 |
| ATR | 0.4131 |
| Shares Float | 44.91M |
| Short Float | 9.03% |
| Short Ratio | 8.08 |
| Volatility | 0.57 |
| Rel Volume | 0.14 |
Performance History
| Week | -2.16% |
| Month | -7.65% |
| Quarter | -7.48% |
| 6 Months | -11.90% |
| YTD | -9.77% |
| Year | +29.19% |
| 3 Years | -21.26% |
| 10 Years | -25.20% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $14.96 | 63,415 |
| 2026-06-17 | $14.86 | 667,000 |
| 2026-06-16 | $14.99 | 397,400 |
| 2026-06-15 | $15.00 | 292,200 |
| 2026-06-12 | $15.08 | 276,300 |
| 2026-06-11 | $15.29 | 340,400 |
| 2026-06-10 | $15.26 | 259,000 |
| 2026-06-09 | $15.65 | 474,000 |
| 2026-06-08 | $15.18 | 381,100 |
| 2026-06-05 | $15.46 | 585,300 |
| 2026-06-04 | $15.35 | 388,400 |
| 2026-06-03 | $14.87 | 1,106,500 |
| 2026-06-02 | $14.98 | 590,200 |
| 2026-06-01 | $15.39 | 774,100 |
| 2026-05-29 | $15.65 | 819,800 |
| 2026-05-28 | $15.59 | 287,800 |
| 2026-05-27 | $15.72 | 297,800 |
| 2026-05-26 | $15.78 | 278,500 |
| 2026-05-22 | $15.92 | 264,100 |
| 2026-05-21 | $16.15 | 455,600 |
| 2026-05-20 | $16.20 | 426,100 |
| 2026-05-19 | $16.20 | 290,800 |
| 2026-05-18 | $16.11 | 454,600 |
About Bausch + Lomb Corporation
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.
đ° Latest News
How the Iconic Cast-Iron Tourist Binoculars Are Fighting to Survive a Cashless World
The Wall Street Journal âĸ 2026-06-14T13:00:00Z
Alignment Healthcare (ALHC) Soars 25.1%: Is Further Upside Left in the Stock?
Zacks âĸ 2026-06-10T10:36:00Z
Bausch + Lomb to lay off employees in Missouri
MedTech Dive âĸ 2026-06-10T10:00:00Z
AstraZenecaâs âextensiveâ obesity drug push; $125M for ultrasound-aided genetic medicine
BioPharma Dive âĸ 2026-06-10T09:12:00Z
Bausch + Lomb Dry Eye Launch Highlights Valuation Gap And Growth Questions
Simply Wall St. âĸ 2026-06-09T18:11:31Z
Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest
StockStory âĸ 2026-05-21T22:44:55Z
3 Profitable Stocks Weâre Skeptical Of
StockStory âĸ 2026-05-19T20:36:55Z
How Investors May Respond To Bausch + Lomb (BLCO) Surgical Launch and EBITDA Momentum
Simply Wall St. âĸ 2026-05-17T02:07:36Z
Bausch + Lomb Corporation (BLCO): Carl C. Icahn Likes This Stock
Insider Monkey âĸ 2026-05-13T19:48:20Z
Americans Are Cutting Spending on Everything Except Healthcare. These 2 Medical Device Stocks Under $30 Are Built to Win
24/7 Wall St. âĸ 2026-05-13T12:57:08Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,887,000,000 | $1,724,000,000 | $1,500,000,000 | $1,384,000,000 |
| Cost Of Revenue | $2,050,000,000 | $1,872,000,000 | $1,642,000,000 | $1,519,000,000 |
| Total Revenue | $5,101,000,000 | $4,791,000,000 | $4,146,000,000 | $3,768,000,000 |
| Operating Revenue | $8,393,000,000 | $7,492,000,000 | $4,131,000,000 | $3,746,000,000 |
| Expenses | ||||
| Interest Expense | $421,000,000 | $399,000,000 | $283,000,000 | $146,000,000 |
| Total Expenses | $4,913,000,000 | $4,585,000,000 | $3,942,000,000 | $3,548,000,000 |
| Other Income Expense | $-96,000,000 | $-56,000,000 | $-102,000,000 | $-7,000,000 |
| Net Non Operating Interest Income Expense | $-409,000,000 | $-384,000,000 | $-268,000,000 | $-140,000,000 |
| Interest Expense Non Operating | $421,000,000 | $399,000,000 | $283,000,000 | $146,000,000 |
| Operating Expense | $2,863,000,000 | $2,713,000,000 | $2,300,000,000 | $2,029,000,000 |
| Other Non Operating Income Expenses | - | - | - | $-1,000,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-360,000,000 | $-317,000,000 | $-260,000,000 | $6,000,000 |
| Net Interest Income | $-409,000,000 | $-384,000,000 | $-268,000,000 | $-140,000,000 |
| Interest Income | $12,000,000 | $15,000,000 | $15,000,000 | $6,000,000 |
| Normalized Income | $-278,400,000 | $-269,400,000 | $-198,800,000 | $11,165,300 |
| Net Income From Continuing And Discontinued Operation | $-360,000,000 | $-317,000,000 | $-260,000,000 | $6,000,000 |
| Total Operating Income As Reported | $113,000,000 | $162,000,000 | $130,000,000 | $207,000,000 |
| Net Income Common Stockholders | $-360,000,000 | $-317,000,000 | $-260,000,000 | $6,000,000 |
| Net Income | $-360,000,000 | $-317,000,000 | $-260,000,000 | $6,000,000 |
| Net Income Including Noncontrolling Interests | $-352,000,000 | $-305,000,000 | $-248,000,000 | $15,000,000 |
| Net Income Continuous Operations | $-352,000,000 | $-305,000,000 | $-248,000,000 | $15,000,000 |
| Pretax Income | $-317,000,000 | $-234,000,000 | $-166,000,000 | $73,000,000 |
| Special Income Charges | $-81,000,000 | $-44,000,000 | $-74,000,000 | $-13,000,000 |
| Interest Income Non Operating | $12,000,000 | $15,000,000 | $15,000,000 | $6,000,000 |
| Operating Income | $188,000,000 | $206,000,000 | $204,000,000 | $220,000,000 |
| Depreciation Amortization Depletion Income Statement | $258,000,000 | $288,000,000 | $240,000,000 | $244,000,000 |
| Depreciation And Amortization In Income Statement | $258,000,000 | $288,000,000 | $240,000,000 | $244,000,000 |
| Amortization Of Intangibles Income Statement | $258,000,000 | $288,000,000 | $240,000,000 | $244,000,000 |
| Gross Profit | $3,051,000,000 | $2,919,000,000 | $2,504,000,000 | $2,249,000,000 |
| Per Share | ||||
| Diluted EPS | $-1.02 | $-0.90 | $-0.74 | $0.02 |
| Basic EPS | $-1.02 | $-0.90 | $-0.74 | $0.02 |
| Other | ||||
| Tax Effect Of Unusual Items | $-14,400,000 | $-8,400,000 | $-40,800,000 | $-1,834,700 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $621,000,000 | $657,000,000 | $601,000,000 | $605,000,000 |
| Total Unusual Items | $-96,000,000 | $-56,000,000 | $-102,000,000 | $-7,000,000 |
| Total Unusual Items Excluding Goodwill | $-96,000,000 | $-56,000,000 | $-102,000,000 | $-7,000,000 |
| Reconciled Depreciation | $421,000,000 | $436,000,000 | $382,000,000 | $379,000,000 |
| EBITDA (Bullshit earnings) | $525,000,000 | $601,000,000 | $499,000,000 | $598,000,000 |
| EBIT | $104,000,000 | $165,000,000 | $117,000,000 | $219,000,000 |
| Diluted Average Shares | $353,800,000 | $351,800,000 | $350,500,000 | $350,000,000 |
| Basic Average Shares | $353,800,000 | $351,800,000 | $350,500,000 | $350,000,000 |
| Diluted NI Availto Com Stockholders | $-360,000,000 | $-317,000,000 | $-260,000,000 | $6,000,000 |
| Minority Interests | $-8,000,000 | $-12,000,000 | $-12,000,000 | $-9,000,000 |
| Tax Provision | $35,000,000 | $71,000,000 | $82,000,000 | $58,000,000 |
| Gain On Sale Of Ppe | $6,000,000 | $5,000,000 | $0 | $0 |
| Other Special Charges | $49,000,000 | $23,000,000 | $3,000,000 | $2,000,000 |
| Impairment Of Capital Assets | $0 | $5,000,000 | $0 | $1,000,000 |
| Restructuring And Mergern Acquisition | $38,000,000 | $21,000,000 | $71,000,000 | $10,000,000 |
| Gain On Sale Of Security | $-15,000,000 | $-12,000,000 | $-28,000,000 | $6,000,000 |
| Amortization | $258,000,000 | $288,000,000 | $240,000,000 | $244,000,000 |
| Research And Development | $371,000,000 | $343,000,000 | $324,000,000 | $307,000,000 |
| Selling General And Administration | $2,234,000,000 | $2,082,000,000 | $1,736,000,000 | $1,478,000,000 |
| Write Off | - | - | - | - |
Fetched: 2026-06-17
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-1,591,000,000 | $-1,544,000,000 | $-1,314,000,000 | $468,000,000 |
| Total Assets | $14,022,000,000 | $13,469,000,000 | $13,442,000,000 | $11,144,000,000 |
| Total Non Current Assets | $11,045,000,000 | $10,681,000,000 | $10,700,000,000 | $9,007,000,000 |
| Other Non Current Assets | $310,000,000 | $294,000,000 | $225,000,000 | $215,000,000 |
| Non Current Deferred Assets | $934,000,000 | $885,000,000 | $921,000,000 | $927,000,000 |
| Non Current Deferred Taxes Assets | $934,000,000 | $885,000,000 | $921,000,000 | $927,000,000 |
| Goodwill And Other Intangible Assets | $8,039,000,000 | $8,017,000,000 | $8,164,000,000 | $6,565,000,000 |
| Other Intangible Assets | $3,281,000,000 | $3,494,000,000 | $3,589,000,000 | $2,058,000,000 |
| Current Assets | $2,977,000,000 | $2,788,000,000 | $2,742,000,000 | $2,137,000,000 |
| Other Current Assets | $383,000,000 | $410,000,000 | $541,000,000 | $405,000,000 |
| Restricted Cash | $14,000,000 | $11,000,000 | $3,000,000 | $26,000,000 |
| Inventory | $976,000,000 | $1,036,000,000 | $1,028,000,000 | $628,000,000 |
| Receivables | $1,221,000,000 | $1,026,000,000 | $839,000,000 | $724,000,000 |
| Accounts Receivable | $1,221,000,000 | $1,026,000,000 | $839,000,000 | $724,000,000 |
| Allowance For Doubtful Accounts Receivable | $-17,000,000 | $-18,000,000 | $-21,000,000 | $-22,000,000 |
| Gross Accounts Receivable | $1,238,000,000 | $1,044,000,000 | $860,000,000 | $746,000,000 |
| Cash Cash Equivalents And Short Term Investments | $383,000,000 | $305,000,000 | $331,000,000 | $354,000,000 |
| Cash And Cash Equivalents | $383,000,000 | $305,000,000 | $331,000,000 | $354,000,000 |
| Prepaid Assets | - | - | - | $405,000,000 |
| Debt | ||||
| Net Debt | $4,699,000,000 | $4,479,000,000 | $4,231,000,000 | $2,082,000,000 |
| Total Debt | $5,082,000,000 | $4,784,000,000 | $4,562,000,000 | $2,436,000,000 |
| Long Term Debt And Capital Lease Obligation | $5,043,000,000 | $4,744,000,000 | $4,532,000,000 | $2,411,000,000 |
| Long Term Debt | $5,043,000,000 | $4,744,000,000 | $4,532,000,000 | $2,411,000,000 |
| Current Debt And Capital Lease Obligation | $39,000,000 | $40,000,000 | $30,000,000 | $25,000,000 |
| Current Debt | $39,000,000 | $40,000,000 | $30,000,000 | $25,000,000 |
| Other Current Borrowings | - | - | - | $25,000,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $7,503,000,000 | $6,925,000,000 | $6,522,000,000 | $4,043,000,000 |
| Total Non Current Liabilities Net Minority Interest | $5,583,000,000 | $5,187,000,000 | $4,943,000,000 | $2,747,000,000 |
| Other Non Current Liabilities | $521,000,000 | $430,000,000 | $397,000,000 | $329,000,000 |
| Non Current Deferred Liabilities | $19,000,000 | $13,000,000 | $14,000,000 | $7,000,000 |
| Non Current Deferred Taxes Liabilities | $19,000,000 | $13,000,000 | $14,000,000 | $7,000,000 |
| Current Liabilities | $1,920,000,000 | $1,738,000,000 | $1,579,000,000 | $1,296,000,000 |
| Other Current Liabilities | $487,000,000 | $427,000,000 | $400,000,000 | $342,000,000 |
| Payables And Accrued Expenses | $1,144,000,000 | $1,041,000,000 | $916,000,000 | $733,000,000 |
| Interest Payable | $57,000,000 | $35,000,000 | - | - |
| Payables | $388,000,000 | $389,000,000 | $522,000,000 | $370,000,000 |
| Accounts Payable | $388,000,000 | $389,000,000 | $522,000,000 | $370,000,000 |
| Equity | ||||
| Common Stock Equity | $6,448,000,000 | $6,473,000,000 | $6,850,000,000 | $7,033,000,000 |
| Total Equity Gross Minority Interest | $6,519,000,000 | $6,544,000,000 | $6,920,000,000 | $7,101,000,000 |
| Stockholders Equity | $6,448,000,000 | $6,473,000,000 | $6,850,000,000 | $7,033,000,000 |
| Gains Losses Not Affecting Retained Earnings | $-1,184,000,000 | $-1,385,000,000 | $-1,245,000,000 | $-1,258,000,000 |
| Other Equity Adjustments | $-1,184,000,000 | $-1,385,000,000 | $-1,245,000,000 | $-1,258,000,000 |
| Retained Earnings | $-931,000,000 | $-571,000,000 | $-254,000,000 | $6,000,000 |
| Other Equity Interest | - | - | - | - |
| Other | ||||
| Ordinary Shares Number | $354,209,319 | $352,402,374 | $350,913,804 | $350,000,749 |
| Share Issued | $354,209,319 | $352,402,374 | $350,913,804 | $350,000,749 |
| Tangible Book Value | $-1,591,000,000 | $-1,544,000,000 | $-1,314,000,000 | $468,000,000 |
| Invested Capital | $11,530,000,000 | $11,257,000,000 | $11,412,000,000 | $9,469,000,000 |
| Working Capital | $1,057,000,000 | $1,050,000,000 | $1,163,000,000 | $841,000,000 |
| Total Capitalization | $11,491,000,000 | $11,217,000,000 | $11,382,000,000 | $9,444,000,000 |
| Minority Interest | $71,000,000 | $71,000,000 | $70,000,000 | $68,000,000 |
| Additional Paid In Capital | $8,563,000,000 | $8,429,000,000 | $8,349,000,000 | $8,285,000,000 |
| Capital Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | $250,000,000 | $230,000,000 | $233,000,000 | $196,000,000 |
| Current Accrued Expenses | $756,000,000 | $652,000,000 | $394,000,000 | $363,000,000 |
| Goodwill | $4,758,000,000 | $4,523,000,000 | $4,575,000,000 | $4,507,000,000 |
| Net PPE | $1,762,000,000 | $1,485,000,000 | $1,390,000,000 | $1,300,000,000 |
| Accumulated Depreciation | $-1,896,000,000 | $-1,684,000,000 | $-1,630,000,000 | $-1,515,000,000 |
| Gross PPE | $3,658,000,000 | $3,169,000,000 | $3,020,000,000 | $2,815,000,000 |
| Leases | $400,000,000 | $362,000,000 | $347,000,000 | $335,000,000 |
| Construction In Progress | $525,000,000 | $458,000,000 | $347,000,000 | $237,000,000 |
| Machinery Furniture Equipment | $1,943,000,000 | $1,674,000,000 | $1,657,000,000 | $1,585,000,000 |
| Buildings And Improvements | $743,000,000 | $632,000,000 | $624,000,000 | $614,000,000 |
| Land And Improvements | $47,000,000 | $43,000,000 | $45,000,000 | $44,000,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $635,000,000 | $675,000,000 | $667,000,000 | $421,000,000 |
| Work In Process | $98,000,000 | $99,000,000 | $100,000,000 | $44,000,000 |
| Raw Materials | $243,000,000 | $262,000,000 | $261,000,000 | $163,000,000 |
| Line Of Credit | - | - | - | $0 |
| Current Provisions | - | - | - | $85,000,000 |
| Other Properties | - | - | - | $335,000,000 |
Fetched: 2026-06-17
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-66,000,000 | $-59,000,000 | $-198,000,000 | $170,000,000 |
| Operating Activities | ||||
| Operating Cash Flow | $283,000,000 | $232,000,000 | $-17,000,000 | $345,000,000 |
| Cash Flow From Continuing Operating Activities | $283,000,000 | $232,000,000 | $-17,000,000 | $345,000,000 |
| Operating Gains Losses | $-8,000,000 | $-8,000,000 | $-1,000,000 | $-13,000,000 |
| Investing Activities | ||||
| Capital Expenditure | $-349,000,000 | $-291,000,000 | $-181,000,000 | $-175,000,000 |
| Investing Cash Flow | $-455,000,000 | $-412,000,000 | $-2,109,000,000 | $-215,000,000 |
| Cash Flow From Continuing Investing Activities | $-455,000,000 | $-412,000,000 | $-2,109,000,000 | $-215,000,000 |
| Net Other Investing Changes | $7,000,000 | $2,000,000 | $1,000,000 | - |
| Financing Activities | ||||
| Financing Cash Flow | $225,000,000 | $178,000,000 | $2,078,000,000 | $81,000,000 |
| Cash Flow From Continuing Financing Activities | $225,000,000 | $178,000,000 | $2,078,000,000 | $81,000,000 |
| Net Other Financing Charges | $-36,000,000 | $-23,000,000 | $-37,000,000 | $-2,377,000,000 |
| Other | ||||
| Repayment Of Debt | $-3,096,000,000 | $-430,000,000 | $-161,000,000 | $-13,000,000 |
| Issuance Of Debt | $3,357,000,000 | $631,000,000 | $2,276,000,000 | $2,471,000,000 |
| Interest Paid Supplemental Data | $380,000,000 | $415,000,000 | $238,000,000 | $132,000,000 |
| Income Tax Paid Supplemental Data | $59,000,000 | $91,000,000 | $64,000,000 | $83,000,000 |
| End Cash Position | $397,000,000 | $316,000,000 | $334,000,000 | $380,000,000 |
| Beginning Cash Position | $316,000,000 | $334,000,000 | $380,000,000 | $177,000,000 |
| Effect Of Exchange Rate Changes | $28,000,000 | $-16,000,000 | $2,000,000 | $-8,000,000 |
| Changes In Cash | $53,000,000 | $-2,000,000 | $-48,000,000 | $211,000,000 |
| Net Issuance Payments Of Debt | $261,000,000 | $201,000,000 | $2,115,000,000 | $2,458,000,000 |
| Net Long Term Debt Issuance | $261,000,000 | $201,000,000 | $2,115,000,000 | $2,458,000,000 |
| Long Term Debt Payments | $-3,096,000,000 | $-430,000,000 | $-161,000,000 | $-13,000,000 |
| Long Term Debt Issuance | $3,357,000,000 | $631,000,000 | $2,276,000,000 | $2,471,000,000 |
| Interest Received Cfi | $12,000,000 | $13,000,000 | $13,000,000 | $0 |
| Net Investment Purchase And Sale | $-3,000,000 | $2,000,000 | $-1,000,000 | $5,000,000 |
| Sale Of Investment | $8,000,000 | $14,000,000 | $16,000,000 | $22,000,000 |
| Purchase Of Investment | $-11,000,000 | $-12,000,000 | $-17,000,000 | $-17,000,000 |
| Net Business Purchase And Sale | $-122,000,000 | $-138,000,000 | $-1,941,000,000 | $-45,000,000 |
| Purchase Of Business | $-122,000,000 | $-138,000,000 | $-1,941,000,000 | $-45,000,000 |
| Net PPE Purchase And Sale | $-349,000,000 | $-291,000,000 | $-181,000,000 | $-175,000,000 |
| Purchase Of PPE | $-349,000,000 | $-291,000,000 | $-181,000,000 | $-175,000,000 |
| Change In Working Capital | $18,000,000 | $-87,000,000 | $-287,000,000 | $-19,000,000 |
| Change In Payables And Accrued Expense | $108,000,000 | $126,000,000 | $245,000,000 | $189,000,000 |
| Change In Payable | $108,000,000 | $126,000,000 | $245,000,000 | $189,000,000 |
| Change In Account Payable | $108,000,000 | $126,000,000 | $245,000,000 | $189,000,000 |
| Change In Prepaid Assets | $20,000,000 | $161,000,000 | $-147,000,000 | $-7,000,000 |
| Change In Inventory | $38,000,000 | $-147,000,000 | $-264,000,000 | $-106,000,000 |
| Change In Receivables | $-148,000,000 | $-227,000,000 | $-121,000,000 | $-95,000,000 |
| Changes In Account Receivables | $-148,000,000 | $-227,000,000 | $-121,000,000 | $-95,000,000 |
| Other Non Cash Items | $56,000,000 | $83,000,000 | $52,000,000 | $-15,000,000 |
| Stock Based Compensation | $149,000,000 | $92,000,000 | $74,000,000 | $62,000,000 |
| Provisionand Write Offof Assets | $31,000,000 | $26,000,000 | $21,000,000 | $25,000,000 |
| Asset Impairment Charge | $0 | $5,000,000 | $0 | $1,000,000 |
| Deferred Tax | $-32,000,000 | $-10,000,000 | $-10,000,000 | $-90,000,000 |
| Deferred Income Tax | $-32,000,000 | $-10,000,000 | $-10,000,000 | $-90,000,000 |
| Depreciation Amortization Depletion | $421,000,000 | $436,000,000 | $382,000,000 | $379,000,000 |
| Depreciation And Amortization | $421,000,000 | $436,000,000 | $382,000,000 | $379,000,000 |
| Gain Loss On Investment Securities | $-10,000,000 | $-13,000,000 | $-13,000,000 | $-6,000,000 |
| Net Foreign Currency Exchange Gain Loss | $2,000,000 | $10,000,000 | $12,000,000 | $-7,000,000 |
| Net Income From Continuing Operations | $-352,000,000 | $-305,000,000 | $-248,000,000 | $15,000,000 |
| Amortization Cash Flow | - | - | $382,000,000 | $379,000,000 |
| Amortization Of Intangibles | - | - | $382,000,000 | $379,000,000 |
| Net Intangibles Purchase And Sale | - | - | - | $0 |
| Purchase Of Intangibles | - | - | - | $0 |
Fetched: 2026-06-17